Cargando…

Tumefactive brain lesion with rapid cavity formation associated with anti-aquaporin-4 antibody

Detalles Bibliográficos
Autores principales:	Uehara, Takuya, Beck, Goichi, Baba, Kousuke, Mihara, Masahito, Okuno, Tatsusada, Sumi, Hisae, Nakatsuji, Yuji, Mochizuki, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841638/ https://www.ncbi.nlm.nih.gov/pubmed/27144220 http://dx.doi.org/10.1212/NXI.0000000000000230

Ejemplares similares

Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies
por: Yamashita, Rika, et al.
Publicado: (2020)

Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A(2)β Knockout Mice
por: Beck, Goichi, et al.
Publicado: (2016)

Deficiency of Calcium-Independent Phospholipase A2 Beta Induces Brain Iron Accumulation through Upregulation of Divalent Metal Transporter 1
por: Beck, Goichi, et al.
Publicado: (2015)

Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy
por: Meier, Kolja, et al.
Publicado: (2020)

BAFF Controls Neural Cell Survival through BAFF Receptor
por: Tada, Satoru, et al.
Publicado: (2013)

Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET
por: Kato, Hiroki, et al.
Publicado: (2020)

(11)C-Acetate PET Imaging in Patients with Multiple Sclerosis
por: Takata, Kazushiro, et al.
Publicado: (2014)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2019)

Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency
por: Beck, Goichi, et al.
Publicado: (2016)

Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
por: Jain, Promil, et al.
Publicado: (2017)

Recurrent tumefactive demyelinating lesions in an elderly woman
por: Weil, Erika L., et al.
Publicado: (2022)

Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner
por: Honorat, Josephe A., et al.
Publicado: (2017)

Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation
por: Shimizu, Mikito, et al.
Publicado: (2020)

Reply to: Myopathy in Myasthenia Positive for Antibodies Against MuSK, Lrp4, and Titin
por: Yamashita, Rika, et al.
Publicado: (2020)

Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod
por: Okada, Kazumasa, et al.
Publicado: (2018)

Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome
por: Ekmekci, Ozgul, et al.
Publicado: (2018)

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
por: Brod, Staley A, et al.
Publicado: (2019)

Morel-Lavallee Syndrome: A Rare Tumefactive Lesion
por: Labied, Mohamed, et al.
Publicado: (2020)

Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson’s disease patients
por: Araki, Katsuya, et al.
Publicado: (2015)

RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS
por: Shimizu, Mikito, et al.
Publicado: (2023)

Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma
por: Thebault, Simon, et al.
Publicado: (2018)

High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction
por: Sumi-Akamaru, Hisae, et al.
Publicado: (2016)

Xanthine Oxidase Mediates Axonal and Myelin Loss in a Murine Model of Multiple Sclerosis
por: Honorat, Josephe Archie, et al.
Publicado: (2013)

Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
por: Nakamura, Masataka, et al.
Publicado: (2017)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease with Frequent Cerebellitis
por: Ishikura, Teruyuki, et al.
Publicado: (2022)

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI
por: De Simone, Marta, et al.
Publicado: (2017)

AZD-1222: Tumefactive demyelinating brain lesion : case report
Publicado: (2022)

Reply to comment on: Dietary yeasts reduce inflammation in central nervous system via microflora
por: Takata, Kazushiro, et al.
Publicado: (2015)

Dietary Yeasts Reduce Inflammation in Central Nerve System via Microflora
por: Takata, Kazushiro, et al.
Publicado: (2015)

Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2011)

Tuméfaction gingivale chronique
por: Cerci, Marielle, et al.
Publicado: (2020)

Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
por: Gavra, Maria, et al.
Publicado: (2011)

Progressive tumefactive fibroinflammatory lesion of the infratemporal fossa treated by radiation therapy
por: Hoebers, Frank J.P., et al.
Publicado: (2012)

Neuroimaging features of tumefactive demyelinating lesions: A rare case report
por: Febyan, et al.
Publicado: (2020)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions
por: Zhang, Yajing, et al.
Publicado: (2023)

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels
por: Koda, Toru, et al.
Publicado: (2018)

Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder
por: Yamashita, Kazuya, et al.
Publicado: (2018)

Tumefactive Multiple Sclerosis in Taiwan
por: Kuan, Yi-Chun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e67loh86fopqdnssv6a0tm0uqu